{"id":"W2125620887","doi":"10.1016/s1470-2045(11)70033-x","title":"Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":611,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Medicine; Internal medicine; Interim analysis; Breast cancer; Oncology; Clinical endpoint; Population; Adjuvant; Surgery; Clinical trial; Hazard ratio; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004106796,0.002524831,0.006905101,0.0006524436,0.0008286664,0.001964919,0.001606198,0.004299411,0.00563084],"category_scores_gemma":[0.00520819,0.001226116,0.006060629,0.0009387553,0.002016777,0.002383214,0.0008949673,0.005769826,0.0009304335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001869065,"about_ca_system_score_gemma":0.001623591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003359125,"about_ca_topic_score_gemma":0.003949807,"domain_scores_codex":[0.9973013,0.001415005,0.0001905354,0.0004354574,0.0001502246,0.000507383],"domain_scores_gemma":[0.9969304,0.001033168,0.0008012664,0.0003707326,0.0002087652,0.0006556513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9939172,0.001214197,0.000477851,0.0002282359,0.001069727,0.00002113695,0.00002791905,0.0001164492,0.0002782473,0.00002247117,0.0001662266,0.00246045],"study_design_scores_gemma":[0.9484632,0.04538711,0.003338135,0.0000619971,0.001906469,0.00002242846,0.00003222272,0.0002081039,0.0001377997,0.0001067337,0.0003143454,0.00002136817],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825045,0.01084186,0.0005645985,0.0009606966,0.00133645,0.00169001,0.000851227,0.00007874102,0.00117185],"genre_scores_gemma":[0.9891058,0.003408131,0.0005484837,0.000983514,0.0006963568,0.001664515,0.00106648,0.00001954929,0.002507136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006905101,"threshold_uncertainty_score":0.02171904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0317431920055709,"score_gpt":0.327746268557953,"score_spread":0.2960030765523821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}